Found 471 articles for: "retinoids"
Efficacy of Topical Cholesterol and Statin Combination Therapy in the Treatment of Porokeratosis: A Systematic Review and Meta-Analysis
December 2023 | Volume 22 | Issue 12 | Original Article | 1160 | Copyright © December 2023
Background: Porokeratosis is a group of disorders characterized by aberrant skin keratinization secondary to genetic alterations in the mevalonate pathway, which participates in ...
Read MoreA Pilot Study to Evaluate the Efficacy and Tolerability of a Topical Combination Serum for the Improvement of Aged Skin
December 2023 | Volume 22 | Issue 12 | Original Article | 1204 | Copyright © December 2023
Background: With intrinsic aging, the epidermis becomes thinner and fine wrinkles appear. Extrinsic aging, or photoaging, is characterized by deep wrinkles, skin laxity, and hype...
Read MoreTopical Treatments for Melasma and Post-inflammatory Hyperpigmentation
November 2023 | Volume 22 | Issue 11 | Original Article | 1118 | Copyright © November 2023
Background: Dyschromia is one of the most common reasons for patients to seek dermatological care, especially among individuals with skin of color. Most cases present as melasma ...
Read MoreA Prospective, Multicenter, Study of Laser-Activated Gold Microparticles for Treating Patients Using Concomitant Topical Retinoids for Mild-to-Moderate Inflammatory Acne
November 2023 | Volume 22 | Issue 11 | Original Article | 1094 | Copyright © November 2023
Gold microparticles are indicated as an accessory to 1064 nm lasers to facilitate photo-thermal heating of sebaceous glands for treating mild-to-moderate inflammatory acne vulgaris (Sebacia Micro...
Read MoreSuccessful Treatment of Lichen Planus With Oral Upadacitinib
October 2023 | Volume 22 | Issue 10 | Case Reports | 1058 | Copyright © October 2023
Lichen planus is an auto-inflammatory skin disorder marked by intensely pruritic, violaceous papules that commonly affect the extremities of middle-aged adults.1 There are several trea...
Read MoreA Review of the Efficacy of Topical Statins for Treating Disseminated Superficial Actinic Porokeratosis
October 2023 | Volume 22 | Issue 10 | Original Article | 1053 | Copyright © October 2023
Porokeratosis is a rare group of acquired or hereditary dermatoses characterized by linear or annular plaques with a keratotic border. DSAP is the most common porokeratosis, and lesions range fro...
Read MoreTopical Treatments for Photoaged Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 867 | Copyright © September 2023
Background: Photoaging due to cumulative lifetime ultraviolet light exposure is the greatest contributing factor to facial aging. With the continued growth of the population of i...
Read MoreLong-Term Efficacy and Tolerability of a Daily Serum for Rejuvenation and Prejuvenation of Facial Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 917 | Copyright © September 2023
Onjectives: To evaluate the long-term efficacy and tolerance of an anti-aging daily serum (AADS) when used twice-daily over 12 weeks by women with moderate skin fatigue and overa...
Read MoreClinical Trial of Alpha and Beta Defensin Skin Care Regimen for Improvement of Periocular Wrinkles
September 2023 | Volume 22 | Issue 9 | Original Article | 874 | Copyright © September 2023
Background: Defensins recruit leucine-rich repeat-containing G protein-coupled receptor 6 positive (Lgr6+) stem cells which ultimately regenerate new basal stem cells, healthy ke...
Read MoreEvaluation of a Neck Cream Developed to Enhance Nitric Oxide Availability in Aging Skin
September 2023 | Volume 22 | Issue 9 | Original Article | 881 | Copyright © September 2023
Background: To meet the unique needs of aging skin of the neck, a new neck cream that enhances nitric oxide availability has been developed to visibly improve signs of aging and ...
Read MoreINDIVIDUAL ARTICLE: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment
August 2023 | Volume 22 | Issue 8 | Supplement Individual Articles | SF381621s5 | Copyright © August 2023
Most patients with plaque psoriasis exhibit mild-to-moderate disease and topical therapies remain the mainstay treatment option for these patients. The use of topical steroids in combination with...
Read MoreDiagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians
August 2023 | Volume 22 | Issue 8 | Original Article | 742 | Copyright © August 2023
Pediatric psoriasis (PsO) and its associated comorbidities carry physical and psychosocial burdens in children and adolescents, which can negatively impact quality of life. However, features dist...
Read MorePsoriasis and Skin Barrier Dysfunction: The Role of Gentle Cleansers and Moisturizers in Treating Psoriasis
August 2023 | Volume 22 | Issue 8 | Original Article | 773 | Copyright © August 2023
Background: Psoriasis is a chronic immune-mediated dermatologic disorder with multisystemic comorbidities, which is effectively treated with a range of prescription therapies. St...
Read MoreRethinking the Inflammatory Balance in Psoriasis and Atherosclerosis
August 2023 | Volume 22 | Issue 8 | Features | 832 | Copyright © August 2023
Guénin S, Kazemi A, Cline A, et al. Rethinking the inflammatory balance in psoriasis and atherosclerosis. J Drugs Dermatol. 2023;22(8):832-833. doi:10.36849/JDD.7082...
Read MoreA Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults
August 2023 | Volume 22 | Issue 8 | Original Article | 761 | Copyright © August 2023
Psoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing. Topical treatments are first line agents for mild to moderate plaque ...
Read MoreTapinarof, a Novel, First-in-Class, Topical Therapeutic Aryl Hydrocarbon Receptor Agonist for the Management of Psoriasis
August 2023 | Volume 22 | Issue 8 | Original Article | 779 | Copyright © August 2023
Topical treatments remain the foundation of psoriasis management. Tapinarof (VTAMA®; Dermavant Sciences, Inc.) is a first-in-class, non-steroidal, topical, aryl hydrocarbon receptor (AhR) ago...
Read MoreTalquetamab-Induced Grover's Disease
August 2023 | Volume 22 | Issue 8 | Case Reports | 828 | Copyright © August 2023
Kresch M, Guénin S, Mubasher A, et al. Talquetamab-induced Grover’s disease. J Drugs Dermatol. 2023;22(8):828-829. doi:10.36849/JDD.7170...
Read MoreReduction of Erythema in Moderate-Severe Rosacea by a Low Molecular Weight Heparan Sulfate Analog (HSA)
June 2023 | Volume 22 | Issue 6 | Original Article | 546 | Copyright © June 2023
Rosacea changes are a result of an immune mediated response and the angiogenic properties of the LL-37 peptide. This peptide induces an inflammatory signal that activates the NLRP3-mediated inflammaso...
Read MoreIndividual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne
June 2023 | Volume 22 | Issue 6 | Supplement Individual Articles | SF350992s7 | Copyright © June 2023
Acne is a prevalent chronic inflammatory disease that can cause severe psychiatric effects and physical scarring of the skin. Historically, although systemic antiandrogen acne medications have be...
Read MoreThe Many Faces of Pediatric Acne: A Practical Algorithm for Treatment, Maintenance Therapy, and Skincare Recommendations for Pediatric Acne Patients
June 2023 | Volume 22 | Issue 6 | Original Article | 539 | Copyright © June 2023
Media and other results for: "retinoids"